DMC1

DMC1
Name	DMC1
Organism	Homo sapiens

DMC1 DMC1 is a meiosis-specific recombinase protein involved in homologous recombination during meiotic prophase I. It functions alongside other recombination factors to promote strand exchange and crossover formation, and is central to gametogenesis and genomic integrity in eukaryotes.

Introduction

DMC1 operates in the context of meiotic chromosome dynamics studied by investigators from institutions such as Cold Spring Harbor Laboratory, Max Planck Society, University of Cambridge, Harvard University, and Stanford University. Research on DMC1 intersects with findings from work on RAD51, BRCA1, BRCA2, Spo11, and MSH4 and is cited in reviews associated with Nature, Science, Cell, Proceedings of the National Academy of Sciences, and EMBO Journal. Geneticists and cell biologists from programs at National Institutes of Health, Wellcome Trust, and European Molecular Biology Laboratory have elucidated its role during interactions characterized in experiments leveraging models such as Saccharomyces cerevisiae, Mus musculus, Arabidopsis thaliana, Caenorhabditis elegans, and Drosophila melanogaster.

Gene and Protein Structure

The DMC1 gene maps to chromosomal loci identified in comparative maps generated by groups including Human Genome Project collaborators and cytogenetic studies linked to UCSC Genome Browser and Ensembl. Structural studies using techniques advanced by teams from Max Planck Institute for Biophysical Chemistry, Brookhaven National Laboratory, and European Synchrotron Radiation Facility revealed that the DMC1 protein forms a helical nucleoprotein filament similar to structures reported for RAD51 and RecA with ATP-binding motifs conserved across recombinases. Crystallographers associated with MRC Laboratory of Molecular Biology, Riken, and Columbia University resolved oligomeric assemblies and DNA-binding interfaces, highlighting residues implicated in ATP hydrolysis and strand exchange comparable to observations in RecA and bacterial recombinases studied by Stanford University groups.

Expression and Regulation

DMC1 expression is tightly regulated during meiosis by transcriptional programs characterized by factors such as TFDP1, E2F1, and chromatin modifiers studied at Cold Spring Harbor Laboratory and MIT. Post-translational regulation involves phosphorylation and interactions with mediator proteins including RAD51, BRCA2, and HORMAD1; these regulatory interactions have been probed in laboratories at Johns Hopkins University, University of California, San Francisco, and Yale University. Cell-cycle control linked to meiotic entry described in reports from European Molecular Biology Laboratory, Max Planck Institute, and NIH shows coordinated expression with Spo11-induced DNA double-strand break formation and processing factors such as MRE11, RAD50, and NBS1.

Role in Meiosis and Recombination

DMC1 catalyzes homology search and strand invasion events central to crossover formation studied in genetic screens at Cambridge University, University of Oxford, and University of Tokyo. Functional assays from Columbia University, UCSF, and CNRS demonstrate that DMC1-dependent recombination promotes synapsis with components of the synaptonemal complex including SYCP1, SYCP2, and SYCP3. Loss-of-function phenotypes characterized in mutant mouse models developed at The Jackson Laboratory and knockout studies reported by EMBL and NIH reveal defects in homolog pairing, unresolved double-strand breaks, and activation of meiotic checkpoints involving ATM, ATR, CHK2, and TP53 pathways. Biochemical reconstitution experiments from Cold Spring Harbor Laboratory and Max Planck Society show cooperative activity between DMC1 and mediator complexes involving RAD52 and MSH4-MSH5.

Clinical Significance and Mutations

Variants in the DMC1 coding sequence have been investigated in cohorts assembled by clinical centers such as Mayo Clinic, Cleveland Clinic, Great Ormond Street Hospital, and consortia including ClinVar and 1000 Genomes Project investigators. Missense mutations and rare alleles correlate with reproductive phenotypes reported by reproductive endocrinology groups at Cornell University, University College London, and University of Pennsylvania, including primary ovarian insufficiency and azoospermia in studies published in The Lancet and Human Molecular Genetics. Functional characterization of pathogenic variants performed by teams from Sanger Institute, NIH Clinical Center, and Karolinska Institute often uses mouse and yeast complementation assays to assess defects in filament formation, ATP hydrolysis, or DNA binding. Diagnostic and counseling implications have been discussed in guidelines from organizations such as American Society for Reproductive Medicine and European Society of Human Reproduction and Embryology.

Evolutionary Conservation and Homologs

DMC1 is conserved across eukaryotic lineages with homologs identified in comparative genomics efforts by groups at Broad Institute, Wellcome Sanger Institute, Joint Genome Institute, and Ensembl Genomes. Phylogenetic analyses published by researchers at University of California, Berkeley, Princeton University, and University of Edinburgh place DMC1 within the RecA/RAD51 recombinase superfamily, with functional homologs characterized in Saccharomyces cerevisiae (meiosis studies by Oxford University teams), plant orthologs in Arabidopsis thaliana explored at Max Planck Institute for Plant Breeding Research, and protist homologs identified in projects associated with Marine Biological Laboratory. Comparative protein evolution work from European Bioinformatics Institute and NCBI shows conserved ATPase motifs and DNA-contacting residues paralleling studies of RecA and RAD51 across bacteria, archaea, and eukaryotes.

Category:Meiosis proteins